Fig. 7From: The therapeutic effect of larval saliva and hemolymph of Lucilia sericata on the treatment of Leishmania major lesion in BALB/c mice946In vitro larval products’ effect on both macrophage types infected with Leishmania major at 72 and 120 h compared with glucantime. a Decrease in infection percentage (DI%) in L. major amastigote peritoneal cells. b Decrease in amastigote viability (DV%) in L. major amastigote peritoneal cells. c Decrease in infection percentage (DI%) in L. major amastigote J774A.1 cells. d Decrease in amastigote viability (DV%) in L. major amastigote J774A.1 cellsBack to article page